Disease interception
Detecting and stopping diseases before they break out is a fascinating idea. Disease Interception aims to do just that. The concept envisages diagnosing and treating those affected much earlier than today - before clinical symptoms appear - and interrupting the disease process in the preclinical stage. Disease Interception would mean a paradigm shift for those affected, their relatives, doctors and the healthcare system as a whole. This brings with it questions that extend far beyond medicine, including social, regulatory, legal and ethical issues. In order to answer them, a discourse between all actors is required. The publication “Disease Interception”, supported by Janssen Germany, makes a contribution to this. The editors, Prof. Dr. med. Frank Jessen and Dr. med. Christoph Bug, have invited well-known experts from medicine, research, health industry and society to evaluate the concept of disease interception: D. Berron | F. von Bohlen and Halbach | C. Bug | M. Danner | E. Düzel | M. Hennrich | W. Hoffmann | F. Jessen | F. Knieps | P. Langkafel | J.-M. Löhr | D. Matusiewicz | S. Maul | M.-S. Raab | H. Rebscher | R. Roski | D. Rujescu | C. Stallberg | A. Ullmann | J. Wasem | J. Werner | J. Wiltfang | E. Winkler | I. Zwingmann
Table of contents
New in the Monitor Health Services Research series: Disease Interception. Here you will find author information with links to the respective articles and interviews.
Preface
Disease Interception – great opportunities and such
Challenges for future medicine
Citation: Jessen, F.: “Disease Interception – great opportunities and challenges for the medicine of the future”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 5-10
Editorial
Bold Hope: Disease Interception
Citation: Roski, R.: “Bold Hope: Disease Interception”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 11-14
The paradigm of disease interception from the patient's perspective
Citation: Danner, M.: “The paradigm of disease interception from the patient’s perspective”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 17-26
Prof. Dr. med. Dr. phil. Eva Winkler
Ethical considerations for disease interception
Citation: Winkler, E.: “Ethical considerations for disease interception”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 27-38
Prof. Dr. med. Jochen A. Werner
Thoughts on the doctor-patient relationship in the context of disease interception
Citation: Werner, J.: “Thoughts on the doctor-patient relationship in the context of disease interception”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 39-47
Prof. Dr. med. Marc Steffen Raab
Opportunities for disease interception in oncology
Citation: Raab, M.-S.: “Chances of Disease Interception in Oncology”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 51-59
Prof. Dr. med. Dan Rujescu,
Dr. med. Stephen Maul
Perspectives on Alzheimer's therapy
Citation: Rujescu, D., Maul, S.: “Perspectives on Alzheimer’s therapy”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 61-67
Prof. Dr. med. Jens Wiltfang
Citation: Wiltfang, J.: “Blood-based diagnostics of preclinical Alzheimer’s dementia: recruitment aid for clinical studies on disease interception in Alzheimer’s disease”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 69-78
Dr. David Berron,
Prof. Dr. med. Emrah Düzel
Digital monitoring of specific cognitive impairments in early Alzheimer's disease
Citation: Berron, D., Düzel, E.: “Digital monitoring of specific cognitive impairments in early Alzheimer’s disease”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 79-91
Dr. Friedrich von Bohlen and Halbach,
Prof. Dr. Johannes-Matthias Löhr
Disease Interception – Oncology & Genetics: Evidence-based interception for prevention and therapy
Citation: von Bohlen und Halbach, F., Löhr, J.-M.: “Disease Interception – Oncology & Genetics: Evidence-based Interception for Prevention and Therapy”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 93-100
Dr. med. Peter Langkafel
Is data the stethoscope of the 21st century?
Citation: Langkafel, P.: “Are data the stethoscope of the 21st century?”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 101-116
Prof. Dr. med. Wolfgang Hoffmann,
Dr. med. Stephen Maul
Citation: Hoffmann, W,. Zwingmann, I.: “Opportunities and challenges of disease interception for dementia diseases from the perspective of health services research”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 119-132
Consideration of disease interception from a health economics perspective
Citation: Matusiewicz, D.: “Consideration of disease interception from a health economics perspective”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 133-145
Citation: Wasem, J.: “Disease Interception: More than a therapeutic and systemic innovation – a paradigm shift for our healthcare system”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 147-155
Michael Hennrich, MP
Citation: Hennrich, M., Stegmaier, P.: “If we assume that the prevalence of Alzheimer's disease will triple worldwide by 2050, we cannot close our eyes to an opportunity like Disease Interception”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 159-166
Prof. Dr. Andrew Ullmann, MP
Citation: Ullmann, A.: “Disease interception offers the chance that diseases that occur particularly in old age, such as dementia, cancer or cardiovascular diseases, could be conquerable in the future”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 167-170
“The health system must focus less on curative activity and more on prevention”
Citation: Knieps, F., Stegmaier, P.: “The health system must focus less on curative activity and more on prevention”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 171-183
“Disease Interception: Potential for harm and benefit remain the measure of all things”
Citation: Rebscher, H., Stegmaier, P.: “Disease Interception: Potential for harm and benefit remain the measure of all things”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 185-197
Dr. Christian Stallberg, LL.M.
Disease Interception as a benefit of statutory health insurance? – Legal challenges and perspectives
Citation: Stallberg, C.: “Disease Interception as a benefit of statutory health insurance? – Legal challenges and perspectives”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 199-215
Dr. med. Christoph Bug
Disease Interception: Making the vision a reality
Citation: Bug, C.: “Disease Interception: Making the Vision a Reality”; in Jessen, F., Bug, C. (eds.): “Disease Interception”, eRelation Verlag, Bonn, 2019, pp. 219-222